Lazard Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,730
| Closed | -$43K | – | 2254 |
|
|
2024
Q2 | $43K | Sell |
1,730
-5,373
| -76% | -$134K | ﹤0.01% | 1951 |
|
|
2024
Q1 | $180K | Buy |
+7,103
| New | +$180K | ﹤0.01% | 1336 |
|
|
2023
Q4 | – | Sell |
-7,909
| Closed | -$147K | – | 2243 |
|
|
2023
Q3 | $147K | Buy |
+7,909
| New | +$147K | ﹤0.01% | 1489 |
|
|
2023
Q1 | – | Sell |
-2,651
| Closed | -$78K | – | 2283 |
|
|
2022
Q4 | $78K | Hold |
2,651
| – | – | ﹤0.01% | 1616 |
|
|
2022
Q3 | $63K | Hold |
2,651
| – | – | ﹤0.01% | 1687 |
|
|
2022
Q2 | $59K | Buy |
+2,651
| New | +$59K | ﹤0.01% | 1734 |
|
|
2022
Q1 | – | Sell |
-1,277
| Closed | -$45K | – | 2319 |
|
|
2021
Q4 | $45K | Hold |
1,277
| – | – | ﹤0.01% | 1780 |
|
|
2021
Q3 | $54K | Buy |
+1,277
| New | +$54K | ﹤0.01% | 1644 |
|
|
2021
Q2 | – | Sell |
-1,791
| Closed | -$73K | – | 1951 |
|
|
2021
Q1 | $73K | Sell |
1,791
-331
| -16% | -$13.5K | ﹤0.01% | 1284 |
|
|
2020
Q4 | $96K | Sell |
2,122
-36
| -2% | -$1.63K | ﹤0.01% | 1191 |
|
|
2020
Q3 | $76K | Hold |
2,158
| – | – | ﹤0.01% | 1070 |
|
|
2020
Q2 | $81K | Buy |
2,158
+302
| +16% | +$11.3K | ﹤0.01% | 1069 |
|
|
2020
Q1 | $53K | Buy |
+1,856
| New | +$53K | ﹤0.01% | 1152 |
|